Related Experiment Video

Updated: May 21, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Peptides: an arrival point in cancer vaccinology

Joerg Willers1, Giovanni Capone, Alberta Lucchese

  • 1Cytos Biotechnology AG, Schlieren, Switzerland.

Frontiers in Bioscience (Scholar Edition)
|June 2, 2012
PubMed

Insights

Therapeutic vaccines for autoimmunity and cancer face challenges like MHC degeneration and immune escape. Defining peptide-peptide interactions is key to advancing vaccinology and cancer vaccine development.

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Therapeutic vaccines are being developed for complex diseases like cancer and autoimmunity.
  • Advances in understanding disease mechanisms drive vaccine research.
  • Monoclonal antibodies offer predictable specificity in therapeutic approaches.

Purpose of the Study:

  • To discuss current vaccine development approaches, focusing on cancer vaccines.
  • To highlight persistent challenges in vaccinology.
  • To emphasize the need for understanding peptide-peptide interactions.

Main Methods:

  • Review of existing literature on therapeutic vaccines.
  • Analysis of challenges in vaccine development, including MHC degeneration and immune escape.
  • Discussion of peptide cross-reactivity and adverse events.

Main Results:

  • Despite advances, significant problems remain in vaccinology.
  • Major histocompatibility complex (MHC) degeneration and immune escape are critical issues.
  • Peptide-peptide interactions require further definition for effective immune response understanding.

Conclusions:

  • Understanding peptide-peptide interactions is crucial for advancing vaccinology.
  • Current approaches to cancer vaccine development need to address unsolved problems.
  • Further research is needed to overcome limitations in therapeutic vaccine design.

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...